€0.00
High-functionality excipient CombiLac® is an integrated, lactosebased, co-processed excipient, specifically designed to ease oral solid dosage form development and manufacture. It comprises 70 % alpha-lactose monohydrate, 20 % microcrystalline cellulose (MCC) and 10 % white, native corn starch, each conforming with Ph.Eur., USP-NF, and JP compendial requirements.
The three individual components are integrated into a monoparticulate structure, which is not separable by physical means. CombiLac® shows improved compaction properties compared to an equivalent admixture of individual ingredients, providing robust tablets with minimal friability.
It assures rapid, hardness-independent tablet disintegration for effective API release, and features powder flow characteristics necessary to enhance dosage form weight uniformity and throughput in DC.
Shelf life / Retest:
24 months
Particle size distribution
[Air jet sieving]
Typical Values
Areas of Application
| Manufacturer |
Meggle |
|---|---|
| Quality |
Compound of Lactose Monohydrate USP/NF, EP, JP, JP and Maize Starch USP/NF, Microcrystalline Cellulose USP/NF |
| Composition |
Compound of Lactose, MCC & Maize Starch |
| Dosage Form |
Tablets |
| Function |
Direct compression and dry granulation of instant release dosage forms |
CELLACTOSE 80€0.00 |
Meggle | Select options |
Benefits